Polyp Clinical Trials

2 recruiting

Polyp Trials at a Glance

150 actively recruiting trials for polyp are listed on ClinicalTrialsFinder across 6 cities in 40 countries. The largest study group is Not Applicable with 53 trials, with the heaviest enrollment activity in Chicago, Houston, and London. Lead sponsors running polyp studies include Chinese University of Hong Kong, AstraZeneca, and Centre hospitalier de l'Université de Montréal (CHUM).

Treatments under study

About Polyp Clinical Trials

Looking for clinical trials for Polyp? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Polyp trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Polyp clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 150 trials

Recruiting

ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia

AsthmaChronic Rhinosinusitis With Nasal Polyps (CRSwNP)
AstraZeneca110 enrolled9 locationsNCT07399665
Recruiting
Not Applicable

Timing of Resumption of Direct Oral Anticoagulants Following Polypectomy

Postpolypectomy Bleeding
The University of Hong Kong194 enrolled1 locationNCT06482333
Recruiting
Phase 3

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps
Sanofi210 enrolled121 locationsNCT06834347
Recruiting
Phase 2

Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study

Chronic Rhinosinusitis With Nasal Polyps
Sanofi64 enrolled24 locationsNCT06914908
Recruiting
Not Applicable

Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

Familial Adenomatous Polyposis
University of Michigan Rogel Cancer Center32 enrolled2 locationsNCT06641310
Recruiting
Not Applicable

Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain140 enrolled1 locationNCT06776042
Recruiting
Phase 3

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps
Sanofi210 enrolled113 locationsNCT06834360
Recruiting

Familial Investigations of Childhood Cancer Predisposition

Hereditary Breast and Ovarian CancerHodgkin LymphomaAdrenocortical Carcinoma+30 more
St. Jude Children's Research Hospital1,500 enrolled1 locationNCT03050268
Recruiting
Not Applicable

A Prospective Study to Evaluate the Performance of a Real-time System in the Estimation of Colorectal Polyp Size

Artificial Intelligence (AI)CRC (Colorectal Cancer)Colonic Polyps
Chinese University of Hong Kong278 enrolled1 locationNCT06957015
Recruiting
Phase 3

A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab

Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca180 enrolled45 locationsNCT06706817
Recruiting

A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients

Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca200 enrolled10 locationsNCT07446738
Recruiting
Phase 3

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Eli Lilly and Company510 enrolled194 locationsNCT06338995
Recruiting
Not Applicable

The Impact of Image-Assisted Colonoscope on Patient Experience, Physician Workload, and Examination Quality

Colorectal Cancer ScreeningColonic Polyps/Colonoscopy/Colorectal NeoplasmsDifficult Colonoscopy+1 more
DONG WU200 enrolled1 locationNCT07541924
Recruiting
Not Applicable

Evaluation of the Impact of a Collaboration Between Hospital and Community Pharmacists at Hospital Discharge

Polypharmacy
Pharmacie des Hopitaux de l'Est Lemanique150 enrolled1 locationNCT06902779
Recruiting
Phase 1Phase 2

Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

Familial Adenomatous Polyposis
Recursion Pharmaceuticals Inc.67 enrolled17 locationsNCT05552755
Recruiting
Phase 2

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

Colorectal CarcinomaFamilial Adenomatous Polyposis
National Cancer Institute (NCI)38 enrolled4 locationsNCT06557733
Recruiting
Not Applicable

PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System

Colorectal PolypColorectal AdenomaColorectal Lesion+5 more
EndoQuest Robotics, Inc.56 enrolled6 locationsNCT06133387
Recruiting
Phase 1

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

Colorectal CarcinomaFamilial Adenomatous PolyposisColorectal Adenomatous Polyp+1 more
National Cancer Institute (NCI)36 enrolled5 locationsNCT05630794
Recruiting
Not Applicable

Prioritising Patient Medication Review: Hospitals Reaching Out

PolypharmacyMedication ReviewGeneral Practitioners+2 more
University of Southern Denmark800 enrolled1 locationNCT06451692
Recruiting
Not Applicable

Clinical Evaluation of a New Platform for Bi-manual Endoscopic Resection in the Rectum and Sigma (EndoTEM)

Adenoma ColonAdenoma Colon Polyp
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)30 enrolled3 locationsNCT07146165